Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDrug

CSPC Pharmaceutical Secures FDA Approval for Clinical Study of JMT106 in GPC3-Positive Tumors

October 27, 2024
CompanyDeals

BioNTech Acquires Pre-Clinical Asset and ADC Technology from Portuguese Biotech CellmAbs

October 27, 2024
CompanyDeals

NVIDIA Expands Healthcare Reach with Amgen’s deCode Partnership at JP Morgan Conference

October 27, 2024
CompanyDeals

Alphabet’s Isomorphic Labs Inks Pharma Partnerships with Eli Lilly and Novartis

October 27, 2024
CompanyDrug

MSD’s Keytruda Gains FDA Approval for Advanced Cervical Cancer Treatment

December 10, 2024
CompanyDeals

Boai NKY Medical Holdings Partners with HuaDao Biopharma for CAR-T Therapy Incubator

December 15, 2025
Policy / Regulatory

China’s NHSA Unveils Measures to Secure Volume-Based Procurement Supply

October 27, 2024
CompanyDrug

BMS’s Mavacamten Used to Treat First Patient with Hypertrophic Cardiomyopathy in Hainan

October 27, 2024
CompanyDeals

Shanghai’s EnjoSim Secures Tens of Millions in Pre-Series A Funding for Expansion

October 27, 2024
CompanyDeals

Pfizer Eyes Further ADC Expansion, Potentially in China, Says Chief Oncology Officer

October 27, 2024
CompanyDrug

CARsgen Therapeutics Gets NMPA Approval for CAR-T Therapy CT011 in Hepatocellular Carcinoma

October 27, 2024
CompanyDrug

Simcere Pharmaceutical Group Gets NMPA Green Light for USP1 Inhibitor SIM0501

October 27, 2024
1 2 … 14 15 16 17 18 … 27 28
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up